NHS pays £50m for US blood plasma firm
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The Department of Health has bought an American blood supplier to ensure long term delivery to the NHS, it will confirm today.
In the first move of its kind, the Government has paid around £50 million to buy Life Resources Incorporated, which will supply around 45 per cent of blood plasma needs for the NHS.
The company is the largest remaining independent US plasma collector and a spokeswoman for the department said the move was for the benefit of NHS patients.
The spokeswoman said the decision to buy the company was taken as it was "the most cost-effective means to make sure we have long term supplies of non-UK blood plasma".
The NHS has been using US-based supplies since 1998 as part of efforts to reduce the risk of the spread of variant CJD.
The US is seen as the only country able to supply the quantity of blood plasma needed in the NHS without the risk of vCJD.
The spokeswoman said: "It was felt in order to make sure there was enough plasma, the best thing to do was to actually buy the company and make sure the supply continues.
"The decision is for the benefit of NHS patients."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments